Active tuberculosis and venous thromboembolism: Association according to international classification of diseases, ninth revision hospital discharge diagnosis codes

Clinical Infectious Diseases

Volumn 58, Issue 4, 2014, Pages 495-501

  Dentan, Charlotte ^a,b   Epaulard, Olivier ^a,b   Seynaeve, Damien ^b   Genty, Céline ^a   Bosson, Jean Luc ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

deep vein thrombosis; Premier Perspective database; pulmonary embolism; tuberculosis; venous thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HOSPITAL DISCHARGE; HUMAN; ICD-9-CM; LUNG EMBOLISM; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEGRO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUBERCULOSIS; UNITED STATES; VENOUS THROMBOEMBOLISM; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; COMPLICATION; INTERNATIONAL CLASSIFICATION OF DISEASES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TUBERCULOSIS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84893281852     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit780     Document Type: Article

References (41)

1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379:1835-46.
2. Verso M, Agnelli G, Ageno W, et al. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry. Thromb Res 2012; 130:369-73.
3. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164:963-8.
4. Samama MM, Combe S, Conard J, Horellou M-H. Risk assessment models for thromboprophylaxis of medical patients. Thromb Res 2012; 129:127-32.
5. Kahn SR, LimW, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141:e195S-226S.
6. Rogers MA, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation 2012; 125:2092-9.
7. Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, Sorensen HT. Acute infections and venous thromboembolism. J Intern Med 2012; 271:608-18.
8. Ogeng'o JA, Obimbo MM, Olabu BO, Gatonga PM, Ong'era D. Pulmonary thromboembolism in an East African tertiary referral hospital. J Thromb Thrombolysis 2011; 32:386-91.
9. Sharif-Kashani B, Bikdeli B, Moradi A, et al. Coexisting venous thromboembolism in patients with tuberculosis. Thromb Res 2010; 125:478-80.
10. Goncalves IM, Alves DC, Carvalho A, do Ceu Brito M, Calvario F, Duarte R. Tuberculosis and venous thromboembolism: a case series. Cases J 2009; 2:9333.
11. Fija?kowska-Morawska JB, Jagodzi?ska M, Nowicki M. Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient. Ann Transplant 2011; 16:107-10.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
14. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43:1130-9.
15. Tagalakis V, Kondal D, Ji Y, et al. Men had a higher risk of recurrent venous thromboembolism than women: a large population study. Gend Med 2012; 9:33-43.
16. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 2006; 368:371-8.
17. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353:1386-9.
18. Buckner TW, Key NS. Venous thrombosis in blacks. Circulation 2012; 125:837-9.
19. Bounameaux H, Rosendaal FR. Venous thromboembolism: why does ethnicity matter? Circulation 2011; 123:2189-91.
20. Shitrit D, Fox L, Preiss R, Raz M, Mtvitzuk A. Incidence of venous thromboembolism in 700 patients with acute tuberculosis [in Hebrew]. Harefuah 2012; 151:208-10, 254.
21. Ambrosetti M, Ferrarese M, Codecasa LR, et al. Incidence of venous thromboembolism in tuberculosis patients. Respir Int Rev Thorac Dis 2006; 73:396.
22. Turken O, Kunter E, Sezer M, et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6:927-32.
23. Robson SC, White NW, Aronson I, Woollgar R, Goodman H, Jacobs P. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol 1996; 93:943-9.
24. Hoogerwerf JJ, de Vos AF, Levi M, et al. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med 2009; 37: 619-25.
25. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 2003; 124:1103-15.
26. Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost 2013; 39:559-66.
27. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha-and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991; 59:3021-5.
28. Hussain R, Shiratsuchi H, Phillips M, Ellner J,Wallis RS. Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin Exp Immunol 2001; 123:210-8.
29. Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988; 56:3313-5.
30. Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 1990; 144:3804-8.
31. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115:3-12.
32. Kothari H, Rao LVM, Vankayalapati R, Pendurthi UR. Mycobacterium tuberculosis infection and tissue factor expression in macrophages. PLoS One 2012; 7:e45700.
33. Lyberg T, Closs O, Prydz H. Effect of purified protein derivative and sonicates of Mycobacterium leprae and Mycobacterium bovis BCG on thromboplastin response in human monocytes in vitro. Infect Immun 1982; 38:855-9.
34. Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre's syndrome due to Fusobacterium necrophorum. Lancet Infect Dis 2012; 12:808-15.
35. Gogna A, Pradhan GR, Sinha RS, Gupta B. Tuberculosis presenting as deep vein thrombosis. Postgrad Med J 1999; 75:104-5.
36. Bergmann J-F, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost 2010; 103:736-48.
37. Nahid P, Horne DJ, Jarlsberg LG, et al. Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study. Clin Infect Dis 2011; 53:291-4.
38. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:201-5.
39. Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Seasonality of tuberculosis in the United States, 1993-2008. Clin Infect Dis 2012; 54:1553-60.
40. Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2012; 21:666-9.
41. Sickbert-Bennett EE, Weber DJ, Poole C, MacDonald PDM, Maillard J-M. Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. Am J Epidemiol 2010; 172:1299-305.